Comparative study of Korean white, red, and black ginseng extract on cholinesterase inhibitory activity and cholinergic function

Journal of Ginseng Research

Volumn 35, Issue 4, 2011, Pages 421-428

  Lee, Mi Ra ^a   Yun, Beom Sik ^a   In, Oh Hyun ^b   Sung, Chang Keun ^a  

^a Chungnam National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Acetylcholinesterase; Alzheimer disease; Butyrylcholinesterase; Panax ginseng; Scopolamine

Indexed keywords

MUS; PANAX GINSENG;

EID: 84930479865     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2011.35.4.421     Document Type: Article

References (24)

1. Birthelmer A, Lazaris A, Riegert C, Marques Pereira P, Koenig J, Jeltsch H, Jackisch R, Cassel JC. Does the release of acetylcholine in septal slices originate from intrinsic cholinergic neurons bearing p75(NTR) receptors? A study using 192 IgG-saporin lesions in rats. Neuroscience 2003;122:1059-1071.
2. Bartus RT. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 2000;163:495-529.
3. Beatty WW, Butters N, Janowsky DS. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neural Biol 1986;45:196-211.
4. Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, Beyring R, Robb S, Kirkham FJ, Engel AG. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A 2001;98:2017-2022.
5. Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S. Cholinesterases: roles in the brain during health and disease. Curr Alzheimer Res 2005;2:307-318.
6. Heinrich M, Lee Teoh H. Galanthamine from snowdrop: the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol 2004;92:147-162.
7. Melzer D. New drug treatment for Alzheimer's disease: lessons for healthcare policy. BMJ 1998;316:762-764.
8. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-1693.
9. Sun BS, Gu LJ, Fang ZM, Wang CY, Wang Z, Sung CK. Determination of 11 ginsenosides in black ginseng developed from Panax ginseng by high performance liquid chromatography. Food Sci Biotechnol 2009;18:561-564.
10. Kang KS, Yamabe N, Kim HY, Okamoto T, Sei Y, Yokozawa T. Increase in the free radical scavenging activities of American ginseng by heat processing and its safety evaluation. J Ethnopharmacol 2007;113:225-232.
11. Nitta H, Matsumoto K, Shimizu M, Ni XH, Watanabe H. Panax ginseng extract improves the scopolamine-induced disruption of 8-arm radial maze performance in rats. Biol Pharm Bull 1995;18:1439-1442.
12. Yamaguchi Y, Higashi M, Kobayashi H. Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats. Eur J Pharmacol 1997;329:37-41.
13. Lee MR, Yun BS, Lui L, Zhang DL, Wang Z, Wang CL, Gu LJ, Wang CY, Mo EK, Sung CK. Effect of black ginseng on memory improvement in the amnesic mice induced by scopolamine. J Ginseng Res 2010;34:51-58.
14. Sun BS. Bioconversion to rare ginsenoside and memory and learning functions of white, red, and black ginsengs [dissertation]. Daejeon: Chungnam National University, 2009.
15. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. A new and rapid colormetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
16. Jamal M, Ameno K, Ameno S, Morishita J, Wang W, Kumihashi M, Ikuo U, Miki T, Ijiri I. Changes in cholinergic function in the frontal cortex and hippocampus of rat exposed to ethanol and acetaldehyde. Neuroscience 2007;144:232-238.
17. Cederberg J, Galli J, Luthman H, Eriksson UJ. Increased mRNA levels of Mn-SOD and catalase in embryos of diabetic rats from a malformation-resistant strain. Diabetes 2000;49:101-107.
18. Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403.
19. Op den Velde W, Stam FC. Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia. J Am Geriatr Soc 1976;24:12-16.
20. Giacobini E. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease? Drugs Aging 2001;18:891-898.
21. Giacobini E. Cholinesterases: new roles in brain function and in Alzheimer's disease. Neurochem Res 2003;28:515-522.
22. Oda Y. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathol Int 1999;49:921-937.
23. Oh JH, Choi BJ, Chang MS, Park SK. Nelumbo nucifera semen extract improves memory in rats with scopolamine-induced amnesia through the induction of choline acetyltransferase expression. Neurosci Lett 2009;461:41-44.
24. Levey AI. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc Natl Acad Sci U S A 1996;93:13541-13546.